Biotech expert: "Microdosing" could prevent trial problems

03/19/2006 | Guardian (London), The

Cambridge Antibody Technology's former chief medical officer says the London clinical trial that put six participants in the hospital suggests new procedures need to be introduced. Dr. David Glover said microdosing, which involves testing drugs on a patient's arm rather than treating the whole person, could avert some trial problems.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA